View Older Stories View More Recent Stories
-
Form 424B2 CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form SCHEDULE 13G/A Citi Trends Inc Filed by: ALLIANCEBERNSTEIN L.P.
-
Form 424B2 CITIGROUP INC
-
Citius Pharmaceuticals (CTXR) Prices 12M Share Offering at $0.25/sh
-
Citius Pharmaceuticals Announces $3 Million Registered Direct Offering
-
Form 424B2 CITIGROUP INC
-
Transaction in Own Shares
-
Form 424B2 CITIGROUP INC
-
Ally Financial (ALLY) PT Raised to $55 at Citi, 'remains our top pick'
-
Form 424B2 CITIGROUP INC
-
Strong US data feeds doubts about Fed December rate cut
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form 424B2 CITIGROUP INC
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Crinetics Pharmaceuticals to Participate in Three Upcoming December Investor Conferences
-
Citi Downgrades CVC Capital Partners plc (CVC:NA) to Neutral
-
Advance Auto Parts (AAP) PT Lowered to $44 at Citi
-
Ascendis Pharma (ASND) PT Lowered to $200 at Citi
-
Citi Reiterates Neutral Rating on Oklo (OKLO), PT $10
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 424B2 CITIGROUP INC

